Select Medical Buyout Faces Scrutiny Over $16.50 Per Share Price — Kaskela Law LLC

Event summary

Select Medical Holdings Corp. (NYSE: SEM) agreed to be acquired by an investment consortium for $16.50 per share in cash on March 2, 2026.
Kaskela Law is investigating the fairness of the buyout, citing potential conflicts of interest and an analyst's higher price target of $19.00 per share.
The transaction, if completed, will delist Select Medical's shares from the NYSE.
Shareholders are encouraged to contact Kaskela Law for information about their legal rights and options.

The big picture

The investigation into Select Medical's buyout highlights the ongoing tension between private equity buyers and public shareholders over fair valuation. This case could set a precedent for how conflicts of interest are addressed in future healthcare sector acquisitions, particularly in transactions involving investment consortia. The outcome will also signal whether analysts' price targets carry significant weight in influencing buyout valuations.

What we're watching

Governance Dynamics: How the investigation into conflicts of interest will impact the transaction's timeline and potential renegotiation of the buyout price.
Valuation Discrepancy: Whether the $16.50 per share offer will hold, given an analyst's higher price target of $19.00.
Shareholder Activism: The pace at which shareholders engage with Kaskela Law to challenge the proposed buyout.